Cosa significa "Chiaro"?
L'animale non porta la mutazione. Non svilupperà la malattia e non lo trasmetterò.
Discover the importance of DNA testing for Canine Malignant Hyperthermia (MH) in dogs. This genetic disorder can lead to severe reactions during anesthesia, placing your furry friend at risk. By identifying the MH gene mutation through a simple DNA test, pet owners can make informed decisions about their dog's health and safety. Early detection allows for proactive management, ensuring a safer experience during veterinary procedures. Investing in a DNA test for Canine Malignant Hyperthermia can ultimately save lives and enhance your dog's well-being. Consult your veterinarian today to learn more about this vital genetic screening. Protect your pup with knowledge and peace of mind!
Canine Malignant Hyperthermia (MH) is a rare genetic disorder triggered by certain anesthetic agents in dogs. It leads to a severe and uncontrolled increase in body temperature, muscle rigidity, and metabolic disturbances. The condition is often linked to mutations in the ryanodine receptor gene. Prompt recognition and immediate treatment are crucial to prevent serious complications or death. Preventive measures include genetic testing and avoiding specific anesthetics in at-risk breeds.
Questo test del DNA è incluso a partire dalla nostra confezione Basic — e fa anche parte dei pack Basic, Standard, Advanced, Complete.
Visualizza i pacchetti di test del DNA →Canine Malignant Hyperthermia (MH) is a rare but serious genetic disorder that affects certain dog breeds. It is characterized by an abnormal and severe response to specific stressors, such as anesthesia or extreme heat, leading to a rapid increase in body temperature and metabolic crisis. If not recognized and treated promptly, MH can be fatal for the affected dog.
Malignant Hyperthermia in dogs is caused by a hereditary defect in the regulation of calcium within muscle cells. This defect leads to uncontrolled muscle contractions and a significant increase in metabolic activity, resulting in a rapid rise in core body temperature. Symptoms often include muscle rigidity, rapid breathing, increased heart rate, and a sudden onset of hyperthermia. The condition is often triggered by certain anesthetic agents or stress, making perioperative management critical.
The disorder is inherited in a manner similar to that observed in humans, with specific genetic mutations affecting calcium regulation pathways. Dogs carrying these mutations are predisposed to developing MH when exposed to triggering factors. Identifying affected dogs through DNA testing allows breeders and veterinarians to make informed decisions to prevent the spread of the disorder and to implement appropriate management strategies for affected animals.
DNA testing for canine MH involves analyzing specific genetic markers associated with the disorder. This test provides valuable information about an individual dog's genetic status, helping to identify carriers or affected animals. Early detection through DNA testing can assist in making preventative choices, such as avoiding certain medications or stressful situations that could trigger a crisis, thereby safeguarding the health and well-being of the dog.
Accurate diagnosis of MH through DNA testing is essential for effective management. Dogs identified as at risk can be provided with tailored anesthetic protocols, monitored closely during procedures, and kept in a stress-free environment. Additionally, knowing a dog’s genetic status helps inform breeding decisions to reduce the prevalence of the disorder within a breed population.
L'animale non porta la mutazione. Non svilupperà la malattia e non lo trasmetterò.
No. L'animale è generalmente sano ma può trasmettergli la mutazione prole.
Porta due copie mutate. I segni clinici sono attesi a seconda la malattia. Non dovrebbe essere allevato.
Alcune malattie sono legate al sesso, quindi la loro espressione varia a seconda sesso dell'animale.
This DNA test detects the mutation associated with Canine Malignant Hyperthermia (MH) in order to identify clear, carrier, or at-risk animals.
Il test del DNA aiuta gli allevatori a pianificare accoppiamenti più sicuri e a ridurre il rischio di trasmettere la mutazione alla prole.
La modalità di ereditarietà riportata per questo test è Autosomica Dominante.
This test analyses the mutation RYR1 c.1643T>C.
Non necessariamente. L'interpretazione dipende dal modello di ereditarietà e dal genotipo risultante.
Roberts M C, Mickelson J R, Patterson E E, Nelson T E, Armstrong P J, Brunson D B, Hogan K. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology. 2001 Sep;95(3):716-25. doi: 10.1097/00000542-200109000-00026.
La tua privacy, la tua scelta
Utilizziamo cookie essenziali per il funzionamento del sito web. I cookie opzionali (come quelli dei fornitori di contenuti incorporati) sono disabilitati per impostazione predefinita e vengono abilitati solo se sei d'accordo. Potrai modificare la tua scelta in ogni momento utilizzando il pulsante “Cookie”.
Richiesto per le funzionalità di base e la sicurezza. Sempre attivato.
Migliora funzionalità come il salvataggio delle preferenze o gli embed senza pubblicità.
Ci aiuta a comprendere l'utilizzo del sito. Disabilitato per impostazione predefinita.
Pubblicità/tracciamento tra siti (alcuni video/mappe incorporati). Disabilitato per impostazione predefinita.